 AUSTIN, Texas, Sept. 29, 2021 PRNewswire -- Natera, Inc. NASDAQ: NTRA, is pleased that the Delaware Federal District Court ruled today that all three patents CareDx has asserted against Natera are invalid as a matter of law under 101 for claiming patent-ineligible subject matter. 